Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

Market Cap	4.85B -4.9%
Revenue (ttm)	453.58M -16.1%
Net Income	73.38M -61.8%
EPS	0.58 -61.6%
Shares Out	127.08M
PE Ratio	65.83
Forward PE	n/a
Dividend	0.80 (2.08%)
Ex-Dividend Date	Jul 18, 2025

Volume	485,467
Average Volume	525,762
Open	38.53
Previous Close	38.87
Day's Range	38.00 - 38.93
52-Week Range	35.78 - 45.00
Beta	0.73
RSI	46.75
Earnings Date	Apr 30, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. Further, it offers infectious disease, fertility, fe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 720
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688075

Financial Performance

In 2025, Assure Tech (Hangzhou)'s revenue was 453.58 million, a decrease of -16.11% compared to the previous year's 540.70 million. Earnings were 73.38 million, a decrease of -61.84%.